The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sinclair Michael since 2015.
This trader's CIK number is 1551246.
At the time of last reporting, Sinclair Michael was the Officer of Opiant Pharmaceuticals, Inc.. (stock ticker symbol OPNT).
Also see all insider trading activities at Opiant Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | OPNT | 0 | $0 | 50,000 | $630,305 | 0 | $0 |
| 2021 | OPNT | 0 | $0 | 150,000 | $2,356,672 | 150,000 | $750,000 |
| 2019 | OPNT | 0 | $0 | 60,000 | $751,200 | 0 | $0 |
| 2017 | OPNT | 3,500 | $24,517 | 0 | $0 | 0 | $0 |
| 2015 | OPNT | 0 | $0 | 1,700 | $5,950 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-13 | OPNT | Sale | 5,491 | 11.09 | 60,895 |
| 2022-06-14 | OPNT | Sale | 7,225 | 10.90 | 78,752 |
| 2022-06-15 | OPNT | Sale | 900 | 10.60 | 9,540 |
| 2022-06-09 | OPNT | Sale | 7,896 | 12.25 | 96,726 |
| 2022-06-06 | OPNT | Sale | 7,688 | 12.94 | 99,482 |
| 2022-06-07 | OPNT | Sale | 800 | 12.86 | 10,288 |
| 2022-06-02 | OPNT | Sale | 9,736 | 13.88 | 135,135 |
| 2022-06-03 | OPNT | Sale | 10,264 | 13.59 | 139,487 |
| 2021-08-23 | OPNT | Option Ex | 65,124 | 5.00 | 325,620 |
| 2021-08-24 | OPNT | Option Ex | 34,607 | 5.00 | 173,035 |
| 2021-08-23 | OPNT | Sale | 65,124 | 16.50 | 1,074,546 |
| 2021-08-25 | OPNT | Option Ex | 50,269 | 5.00 | 251,345 |
| 2021-08-24 | OPNT | Sale | 34,607 | 15.71 | 543,675 |
| 2021-08-25 | OPNT | Sale | 50,269 | 14.69 | 738,451 |
| 2019-09-12 | OPNT | Sale | 60,000 | 12.52 | 751,200 |
| 2017-01-17 | OPNT | Buy | 3,500 | 7.00 | 24,517 |
| 2015-01-15 | LLTP | Sale | 1,700 | 3.50 | 5,950 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sinclair Michael (Officer of Opiant Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.